Orchestra BioMed Reports First Quarter 2023 Financial Result

Hypertension in Pacemaker Patients Global pivotal study evaluating the efficacy and safety of BackBeat CNT in adult patients with hypertension who are indicated for a pacemaker on track to start in... | May 12, 2023

Related Keywords

United States , George Papandreou , Avi Fischer , Kelsey Kirk Ellis , Bob Yedid , David Hochman , Sirolimus Angioinfusion , Medtronic , Nutrition Examination Survey , Terumo Corporation , Drug Administration , Twitter , Development Expenses , Orchestra Biomed Holdings Inc , Linkedin , National Inpatient Survey , National Health , Nasdaq , Health Sciences Acquisition Corp , Exchange Commission On , Biomed Holdings , Orchestra Biomed , Chief Executive Officer , Senior Vice President , Medical Affairs , General Manager , Focal Therapies , Kunal Faldu , Vice President , Beat Cardiac Neuromodulation Therapy , Pacemaker Patients , Administrative Expenses , Strategic Collaboration , Breakthrough Device , Backbeat Cardiac Neuromodulation Therapy , Exchange Commission , Consolidated Statements , Orchestra Biomed Holdings , Nc Stock Exchange , News , Information , Press Release , Hypertension , N , Pacemaker , Patients , Lobal , Pivotal , Study , Valuating , The , Efficacy , End , Safety , F , Backbeat , Want , Adult , Ith , Who , Fire , Syndicated , Or , Track , O , Tart Obio Us68572m1062 ,